Blog Medical Device Lawsuits | Medical Drugs | Women’s Health Lawsuits
Medical device and drug safety still a concern for women despite strides made | Causes, Not Just Cases®
June 11, 2021	| by:	Laura K. Stemkowski
The U.S. Government Accountability Office (GAO) released a report in 2001 that found 8 out of 10 drugs withdrawn from the market between 1997 and 2000 posed a greater risk to women than men. While that report was released two decades ago, it exposed a troubling trend in the United States.
News Motley Rice - Firm Wide
Motley Rice nationally ranked in Chambers USA for first time
May 20, 2021	| by:	Motley Rice
For the first time in Motley Rice’s history, Chambers USA recognized Motley Rice as a nationally ranked plaintiffs’ law firm today in the launch of its 2021 guide in the category of USA – Nationwide: Product Liability: Plaintiffs, Band 1. Motley Rice is one of only three firms nationally ranked as Band 1 in the…
News Antitrust
Motley Rice files suit for gamers who allege restricted sales of PlayStation 5 digital codes violate antitrust laws
May 6, 2021	| by:	Motley Rice
Motley Rice filed the nation’s first proposed class action against Sony today for gamers who allege the company is unlawfully monopolizing the sale of PlayStation digital download codes through its exclusive sales at the Sony PlayStation Store.
News Personal Injury Lawsuits
Hyundai settles mid-trial with Myrtle Beach woman alleging injury caused by faulty Elantra seatback
May 4, 2021	| by:	Motley Rice
Motley Rice reached a settlement mid-trial on May 3, 2021 to resolve a claim filed against Hyundai by a Myrtle Beach woman alleging she suffered major injuries because the seatback in her 2009 Elantra collapsed in a routine rear-end collision in 2016.
News Securities Class Actions
Serena Hallowell joins Motley Rice securities fraud practice leadership
March 15, 2021	| by:	Motley Rice
Hallowell will oversee Motley Rice’s direct action litigation and will litigate securities fraud class actions on behalf of institutional investors that seek to recover investment related losses and to hold corporations accountable for financial malfeasance and misconduct.
News Consumer Fraud Protection
The National Law Journal interviews Marlon Kimpson on ‘historically diverse’ Blackbaud data breach national leadership position
March 9, 2021	| by:	Motley Rice
In an interview with The National Law Journal, Motley Rice securities and consumer fraud lawyer Marlon Kimpson discussed his role as co-lead counsel of what the publication called a “historically diverse” leadership team for plaintiffs in the Blackbaud data breach national consolidated litigation, or MDL, filed in U.S…
News Motley Rice - Firm Wide | Toxic Exposure | Medical Device Lawsuits
Esther Berezofsky awarded NJAJ’s distinguished Gerald B. O’Connor Award
March 2, 2021	| by:	Motley Rice
Motley Rice attorney Esther Berezofsky received the New Jersey Association for Justice’s distinguished Gerald B. O’Connor award for 2021 during a virtual ceremony Feb. 25.
News Medical Device Lawsuits | Women’s Health Lawsuits
Fidelma Fitzpatrick to lead national Paragard IUD lawsuits
February 24, 2021	| by:	Motley Rice
U.S. District Judge Leigh Martin May appointed medical attorney Fidelma Fitzpatrick as a member of the Plaintiffs’ Executive Committee that will lead the MDL for women who allege they suffered severe complications after receiving CooperSurgical’s Pargard® IUD.
News Consumer Fraud Protection
Marlon Kimpson appointed co-lead counsel in Blackbaud data breach MDL
February 18, 2021	| by:	Motley Rice
U.S. District Judge J. Michelle Childs appointed Motley Rice attorney Marlon Kimpson as co-lead counsel for plaintiffs who allege Blackbaud released their most sensitive data to criminals in a ransomware attack and subsequent data breach that compromised the private information of tens-of-thousands of the company’s…
News Consumer Fraud Protection
Preliminary settlement reached in 21st Century Oncology data breach claims
February 12, 2021	| by:	Motley Rice
Cancer care provider 21st Century Oncology reached a preliminary $12.5 million settlement to resolve claims in multidistrict litigation regarding allegations the company neglected to protect the private information of millions of patients in a 2015 data breach.